Lymphoma & Plasma Cell Disorders


Immune surveillance prevents DLBCL

Walter and Eliza Hall Institute Preclinical research indicates that immune cells undergo daily, spontaneous changes that could lead to diffuse...

Conference Coverage

Regimen shows promise for ENKTL

The combination of pegaspargase, gemcitabine, and oxaliplatin (P-Gemox) elicited a high rate of response in this cohort of 60 Chinese patients. P...

Conference Coverage

A new prognostic model for PTCL?

Researchers analyzed nearly 9000 patients diagnosed with PTCL in the US and found evidence to suggest that patient age and race, as well as...


Ibrutinib trial stopped early

Credit: Steven Harbour The phase 3 RESONATE study has been stopped early due to positive results in patients receiving ibrutinib. In this trial...


Brentuximab vedotin approved in Japan

Credit: Linda Bartlett The Japanese Ministry of Health, Labour and Welfare has approved brentuximab vedotin (Adcetris) for the treatment of...